Maintaining Stability: How We're Getting RNA Where It Needs To Go
Source: Cytiva
Combined Therapeutics CSO Thomas Van Cott, Ph.D. and Omega Therapeutics Executive Director, Process Development and Analytical Sciences Jeff Atkinson, Ph.D. discuss stabilization and delivery. In this segment from the Bioprocess Online Live event, mRNA Update: Beyond Prophylactic Vaccines, both panelists share progress on the steps being taken to stabilize and protect RNA therapeutics from manufacturing through CMC and on to patient delivery.
access the Video!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.
Subscribe to Bioprocess Online
X
Subscribe to Bioprocess Online
Cytiva
This website uses cookies to ensure you get the best experience on our website. Learn more